SURGALIGN HOLDINGS INC (SRGA) Stock Price, Quote, News and Overview
NASDAQ:SRGA - Nasdaq - US86882C2044 - Common Stock - Currency: USD
SRGA Quote, Performance and Key Statistics
0.1829
-0.09 (-32.98%)
The current stock price of SRGA is 0.1829 USD. In the past month the price decreased by -75.93%. In the past year, price decreased by -94.35%.
SRGA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 29.9 | 45.13B | ||
| COO | COOPER COS INC/THE | 23.91 | 17.66B | ||
| ALGN | ALIGN TECHNOLOGY INC | 20.39 | 14.22B | ||
| SOLV | SOLVENTUM CORP | 17.55 | 12.61B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 30.7 | 6.01B | ||
| BLCO | BAUSCH + LOMB CORP | 25.4 | 5.55B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.27 | 5.44B | ||
| ICUI | ICU MEDICAL INC | 27.69 | 3.85B | ||
| XRAY | DENTSPLY SIRONA INC | 10.14 | 3.73B | ||
| HAE | HAEMONETICS CORP/MASS | 14.9 | 3.17B | ||
| NEOG | NEOGEN CORP | 25.1 | 2.18B | ||
| UFPT | UFP TECHNOLOGIES INC | 36.31 | 1.95B |
Related stock screener links
About SRGA
Company Profile
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 217 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.
Company Info
SURGALIGN HOLDINGS INC
520 Lake Cook Rd Ste 315
Deerfield ILLINOIS 60015 US
CEO: Terry M. Rich
Employees: 217
Company Website: https://www.surgalign.com/
Phone: 18773436832.0
SURGALIGN HOLDINGS INC / SRGA FAQ
What is the stock price of SURGALIGN HOLDINGS INC today?
The current stock price of SRGA is 0.1829 USD. The price decreased by -32.98% in the last trading session.
What is the ticker symbol for SURGALIGN HOLDINGS INC stock?
The exchange symbol of SURGALIGN HOLDINGS INC is SRGA and it is listed on the Nasdaq exchange.
On which exchange is SRGA stock listed?
SRGA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SURGALIGN HOLDINGS INC stock?
10 analysts have analysed SRGA and the average price target is 2.3 USD. This implies a price increase of 1154.78% is expected in the next year compared to the current price of 0.1829. Check the SURGALIGN HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SURGALIGN HOLDINGS INC worth?
SURGALIGN HOLDINGS INC (SRGA) has a market capitalization of 1.68M USD. This makes SRGA a Nano Cap stock.
How many employees does SURGALIGN HOLDINGS INC have?
SURGALIGN HOLDINGS INC (SRGA) currently has 217 employees.
Is SURGALIGN HOLDINGS INC (SRGA) expected to grow?
The Revenue of SURGALIGN HOLDINGS INC (SRGA) is expected to decline by -37.13% in the next year. Check the estimates tab for more information on the SRGA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SURGALIGN HOLDINGS INC (SRGA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SRGA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SRGA, evaluating the profitability, health, valuation and growth aspects
- SURGALIGN HOLDINGS INC (SRGA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SURGALIGN HOLDINGS INC (SRGA) Sales and EPS estimates to see what analysts future expectations are.
- SURGALIGN HOLDINGS INC (SRGA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SURGALIGN HOLDINGS INC (SRGA) Insider and Institutional Ownership to learn about the owners and their transactions.
- SURGALIGN HOLDINGS INC (SRGA) Stock Chart to make your own analysis
- SURGALIGN HOLDINGS INC (SRGA) Latest news and press-releases to stay up to date.
Does SURGALIGN HOLDINGS INC (SRGA) stock pay dividends?
SRGA does not pay a dividend.
When does SURGALIGN HOLDINGS INC (SRGA) report earnings?
SURGALIGN HOLDINGS INC (SRGA) will report earnings on 2023-08-07, after the market close.
What is the Price/Earnings (PE) ratio of SURGALIGN HOLDINGS INC (SRGA)?
SURGALIGN HOLDINGS INC (SRGA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.81).
SRGA Technical Analysis
SRGA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to SRGA. SRGA has a bad profitability rating. Also its financial health evaluation is rather negative.
SRGA Financial Highlights
Over the last trailing twelve months SRGA reported a non-GAAP Earnings per Share(EPS) of -5.81. The EPS increased by 50.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
SRGA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to SRGA. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of -58.25% and a revenue growth -37.13% for SRGA